Azelastine Hydrochloride + Mometasone FuroateThird Party Manufacturing in India

Azelastine Hydrochloride + Mometasone Furoate works by providing rapid H1 histamine receptor blockade alongside deep, long-acting intracellular glucocorticoid modulation. It acts on the nasal mucosal linings to help the body prevent mast cell degranulation, halt eosinophil migration, and minimize inflammatory nasal secretions. Unlike older oral combinations, it avoids systemic drowsiness while targeting severe sinus inflammation directly at the source. It is highly effective and well-tolerated.

Therapeutic Uses

• Severe Seasonal Allergies: Rapidly clears severe nasal stuffiness, constant sneezing, and post-nasal drip.
• Chronic Rhinosinusitis: Helps decrease mucosal tissue hyperreactivity and persistent sinus inflammation over extended periods.

Why Manufacturers Choose Azelastine Hydrochloride + Mometasone Furoate

Medical practitioners increasingly favor this combination due to its rapid response time and excellent localized safety profile. Partnering for Azelastine Hydrochloride + Mometasone Furoate third party manufacturing in India provides access to modern formulation technology and stable supply pipelines. Our production plants leverage modern, WHO-GMP certified manufacturing halls to keep micro-suspensions stable and prevent nozzle clogging during clinical shelf-life.